I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Josep Tabernero
888
results:
Online X
english X
Format
Online (888)
Mediatypes
Articles (Online) (290)
Bookchapter (Online) (1)
OpenAccess-fulltext (597)
Sorted by: Relevance
Sorted by: Year
?
1
Current and Emerging Treatment Paradigms in Colorectal Canc..:
Salva de Torres, Clara
;
Baraibar, Iosune
;
Saoudi González, Nadia
...
International Journal of Molecular Sciences. 25 (2024) 13 - p. 6967 , 2024
Link:
https://doi.org/10.3390/..
?
2
Cetuximab as a Key Partner in Personalized Targeted Therapy..:
Saoudi González, Nadia
;
Ros, Javier
;
Baraibar, Iosune
...
Cancers. 16 (2024) 2 - p. 412 , 2024
Link:
https://doi.org/10.3390/..
?
3
SEAMARK: phase II study of first-line encorafenib and cetux..:
Elez, Elena
;
Kopetz, Scott
;
Tabernero, Josep
...
Future Oncology. 20 (2024) 11 - p. 653-663 , 2024
Link:
https://doi.org/10.2217/..
?
4
A Randomized Phase III Study of Arfolitixorin versus Leucov..:
Tabernero, Josep
;
Yoshino, Takayuki
;
Stintzing, Sebastian
...
Cancer Research Communications. 4 (2024) 1 - p. 28-37 , 2024
Link:
https://doi.org/10.1158/..
?
5
Drug Cost Avoidance Resulting from Participation in Clinica..:
Carreras, Maria-Josep
;
Renedo-Miró, Berta
;
Valdivia, Carolina
...
Cancers. 16 (2024) 8 - p. 1529 , 2024
Link:
https://doi.org/10.3390/..
?
6
COLUMBIA-1: a randomised study of durvalumab plus oleclumab..:
Segal, Neil H.
;
Tie, Jeanne
;
Kopetz, Scott
...
British Journal of Cancer. , 2024
Link:
https://doi.org/10.1038/..
?
7
CEA-CD3 bispecific antibody cibisatamab with or without ate..:
Segal, Neil H.
;
Melero, Ignacio
;
Moreno, Victor
...
Nature Communications. 15 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1038/..
?
8
Mo1250 PATHOLOGICAL COMPLETE RESPONSE (PCR) TO DURVALUMAB P..:
Molena, Daniela
;
Janjigian, Yelena
;
Al-Batran, Salah-Eddin
...
Gastroenterology. 166 (2024) 5 - p. S-996 , 2024
Link:
https://doi.org/10.1016/..
?
9
Determinants of Metastatic Colorectal Cancer With Permanent..:
Salvà, Francesc
;
Saoudi, Nadia
;
Rodríguez, Marta
...
Clinical Colorectal Cancer. , 2024
Link:
https://doi.org/10.1016/..
?
10
Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor A..:
Steeghs, Neeltje
;
Gomez-Roca, Carlos
;
Rohrberg, Kristoffer S.
...
Clinical Cancer Research. 30 (2024) 13 - p. 2693-2701 , 2024
Link:
https://doi.org/10.1158/..
?
11
Targeting KRAS G12C Mutation in Colorectal Cancer, A Review..:
Ros, Javier
;
Vaghi, Caterina
;
Baraibar, Iosune
...
International Journal of Molecular Sciences. 25 (2024) 6 - p. 3304 , 2024
Link:
https://doi.org/10.3390/..
?
12
Prognostic value of liver metastases in colorectal cancer t..:
Cohen, Romain
;
Raeisi, Morteza
;
Chibaudel, Benoist
...
European Journal of Cancer. 207 (2024) - p. 114160 , 2024
Link:
https://doi.org/10.1016/..
?
13
Plain language summary of the FOENIX-CCA2 study: futibatini..:
Goyal, Lipika
;
Meric-Bernstam, Funda
;
Hollebecque, Antoine
...
Future Oncology. , 2024
Link:
https://doi.org/10.1080/..
?
14
Plain language summary of SUNLIGHT: trifluridine/tipiracil ..:
Prager, Gerald W
;
Taieb, Julien
;
Fakih, Marwan
...
Future Oncology. , 2024
Link:
https://doi.org/10.1080/..
?
15
Tislelizumab plus chemotherapy versus placebo plus chemothe..:
Qiu, Miao-Zhen
;
Oh, Do-Youn
;
Kato, Ken
...
BMJ. , 2024
Link:
https://doi.org/10.1136/..
1-15